
Percutaneous coronary interventional (PCI) procedures are performed throughout hundreds of US institutions every day. With the increasing frequency of these procedures being performed comes an associated rise in certain companion risks, namely access site complications. Implementation of a dedicated access site surveillance and educational program, in tandem with pre-existent strategies to reduce access site complications, can reduce the overall incidence of untoward femoral-access related bleeding events.
July 27, 2012 — With a great deal of practical, clinical feedback from a broad demographic of facilities with differing processes and needs, ScImage has comprehensively improved the workflow and the consequent efficiency of its PicomSRI structured reporting platform.
July 27, 2012 — Major safety fears over supraventricular tachycardia (SVT) medications are threatening many elderly patients, and even encouraging some to opt for surgery, claims a new report by healthcare experts GlobalData.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 27, 2012 — Cook Medical announced general availability of the Aprima Access nonvascular introducer set, the first product in the Aprima drainage portfolio. It is a nonvascular access set used for single-puncture percutaneous access to facilitate placement of a working wire guide for interventional radiology (IR) procedures.
July 27, 2012 — C. R. Bard Inc. announced that its Lutonix technology center has completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial.
July 27, 2012 — Healthcare imaging specialist Barco announces the release of a new version of its MediCal QAWeb Mobile software for viewing digital imaging and communications in medicine (DICOM)-quality medical images on the iPad. The new release features a more intuitive user interface and is compatible with Apple’s third-generation iPad.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

The current Medicare payment system is irreparably flawed and a new, more permanent solution must be reached, American College of Cardiology (ACC) President William Zoghbi, M.D., FACC, told the House Committee on Small Business Subcommittee on Investigations, Oversight, and Regulations Hearing on Health Care Realignment and Regulation.

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and target its ablation to greatly reduce procedure time and substantially improve patient outcomes. The results of the CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) study were published online this week by the Journal of the American College of Cardiology.
A study using CT perfusion imaging showed patients presenting with ischemic stroke may be successfully treated with endovascular or minimally invasive therapy well beyond the eight-hour treatment window considered standard by most neurointerventional practitioners.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 26, 2012 — Any exposure to radiation, no matter how small, has the potential of leading to future health issues, including many types of cancer, medical experts agree. Doing all you can to limit your lifetime radiation exposure should be a priority for patients and health care providers.
July 26, 2012 — Cambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that results of a prospective, 155-patient trial reinforces the value of the Microvolt T-Wave Alternans (MTWA) test as a predictor of life-threatening heart rhythms and sudden cardiac death (SCD). The results were published this week in the journal Kardiologia Polska.
July 26, 2012 — Transgenomic Inc. has announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic Absorption Activation Panel (C-GAAP, formerly PGxPREDICT: Clopidogrel).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 26, 2012 — Angion Biomedica Corp. announced that the first patient was dosed in a Phase II multicenter clinical trial evaluating BB3 for the treatment of heart attack (acute myocardial infarction). The first patient, a 69-year-old man, was treated at Yale-New Haven Hospital in Connecticut. This double-blind, placebo-controlled study is designed to enroll 80 patients following a first heart attack.
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds from the redevelopment commission of the city of Gary, Ind., toward the development of Positron's 70 MeV cyclotron project.
July 25, 2012 — Grady Memorial Hospital has standardized and improved patient education and reduced by 75 percent the amount of time staff spend educating new patients about warfarin by implementing Emmi Solutions’ interactive multimedia program in its Coumadin clinic.